HCR(SH:688500)2023-04-28 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥95,139,759.03, representing a year-on-year increase of 1.02%[5] - The net profit attributable to shareholders was -¥17,561,367.90, indicating a loss compared to the previous year[5] - The net profit after deducting non-recurring gains and losses was -¥21,256,847.41, also reflecting a loss[5] - The net loss for Q1 2023 was CNY 19,883,054.36, compared to a net loss of CNY 3,141,713.40 in Q1 2022, indicating a deterioration in financial performance[21] - The total comprehensive loss for Q1 2023 was CNY 20,250,912.57, compared to a loss of CNY 3,423,812.71 in Q1 2022, highlighting a worsening financial situation[22] Cash Flow - The net cash flow from operating activities was ¥4,232,729.82, with no applicable year-on-year comparison[6] - Net cash flow from operating activities for Q1 2023 was $4,232,729.82, a significant improvement from a net outflow of $37,797,853.11 in Q1 2022[25] - The company reported a total cash inflow from operating activities of $173,459,443.56, which is an increase from $136,822,355.63 in Q1 2022, representing a growth of approximately 27%[25] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,140,711,799.71, a decrease of 6.09% from the end of the previous year[6] - The company's total liabilities decreased to CNY 223,540,871.72 in Q1 2023 from CNY 260,399,028.55 in Q1 2022, a reduction of approximately 14.14%[19] - The total current assets decreased to CNY 1,011,269,861.06 from CNY 1,082,595,395.97, indicating a reduction of approximately 6.57%[17] Research and Development - Research and development expenses totaled ¥10,748,230.70, a decrease of 13.5% compared to the previous year[6] - Research and development expenses rose to CNY 10,748,230.70 in Q1 2023, compared to CNY 8,478,414.70 in Q1 2022, an increase of approximately 27.0%[20] - The proportion of R&D expenses to operating revenue was 11.3%, down by 1.89 percentage points from the previous year[6] Equity and Earnings - The equity attributable to shareholders was ¥908,857,169.78, down by 3.79% compared to the previous year[6] - The company's total equity decreased to CNY 917,170,927.99 in Q1 2023 from CNY 954,244,814.43 in Q1 2022, a decline of about 3.9%[19] - Basic and diluted earnings per share for Q1 2023 were both CNY -0.240, compared to CNY -0.034 in Q1 2022, indicating a significant increase in losses per share[22] Operating Costs - Total operating costs increased significantly to CNY 121,180,481.30 in Q1 2023 from CNY 102,799,320.27 in Q1 2022, marking an increase of about 17.78%[20] - The company reported a significant increase in sales expenses, which rose to CNY 29,786,856.45 in Q1 2023 from CNY 16,326,311.34 in Q1 2022, an increase of approximately 82.8%[20] Cash and Cash Equivalents - The company's cash and cash equivalents increased to CNY 230,237,974.27 from CNY 208,891,521.31, representing a growth of about 10.00%[16] - The total cash and cash equivalents at the end of Q1 2023 amounted to $226,295,581.81, an increase from $186,407,677.64 at the end of Q1 2022[26] Investment Activities - Total cash inflow from investment activities reached $724,609,219.17, compared to $614,716,730.59 in the same period last year, indicating a year-over-year increase of approximately 17.9%[25] - Cash outflow from investment activities was $681,535,745.57, down from $781,338,740.81 in Q1 2022, reflecting a decrease of about 12.8%[25] Other Financial Metrics - The report indicates that there are no significant new strategies or product developments mentioned in the provided content[14] - The company's goodwill remained stable at CNY 25,903,747.39, unchanged from the previous period[17]